Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A van Hout

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Transfusion|September 27, 2007
A probabilistic model for analyzing viral risks of plasma-derived medicinal productsMart P Janssen, Jan Over, Cees L van der Poel, et al.
Mathematical Population Studies|September 27, 2002
Coping with multiple morbidity in a life tableJ J Barendregt, G J Van Oortmarssen, B A Van Hout, et al.
Therapeutic Drug Monitoring|March 2, 1999
Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysisN A van Lent-Evers, R A Mathôt, W P Geus, et al.
The American Journal of Cardiology|October 15, 1995
A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarctionM J de Boer, B A van Hout, A L Liem, et al.
BMC Nursing|March 15, 2022
Nurses' experiences with continuous vital sign monitoring on the general surgical ward: a qualitative study based on the Behaviour Change WheelJ P L Leenen, E M Dijkman, A van Hout, et al.
Advances in Therapy|January 8, 2022
Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making ApproachMarjanne A Piena, Sonja Kroep, Claire Simons, et al.
Transfusion|June 1, 2006
Costs and benefits of bacterial culturing and pathogen reduction in the NetherlandsMart P Janssen, Cees L van der Poel, Erik Buskens, et al.
Transfusion|September 2, 2011
Cost-effectiveness of additional blood screening tests in the NetherlandsBarbara A Borkent-Raven, Mart P Janssen, Cees L van der Poel, et al.
Haematologica|January 29, 2011
A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia AKathelijn Fischer, Maurice E Pouw, Daniel Lewandowski, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 9, 2002
Association between joint bleeds and Pettersson scores in severe haemophiliaK Fischer, B A van Hout, J G van der Bom, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Transfusion|September 27, 2007
A probabilistic model for analyzing viral risks of plasma-derived medicinal productsMart P Janssen, Jan Over, Cees L van der Poel, et al.
Mathematical Population Studies|September 27, 2002
Coping with multiple morbidity in a life tableJ J Barendregt, G J Van Oortmarssen, B A Van Hout, et al.
Therapeutic Drug Monitoring|March 2, 1999
Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysisN A van Lent-Evers, R A Mathôt, W P Geus, et al.
The American Journal of Cardiology|October 15, 1995
A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarctionM J de Boer, B A van Hout, A L Liem, et al.
BMC Nursing|March 15, 2022
Nurses' experiences with continuous vital sign monitoring on the general surgical ward: a qualitative study based on the Behaviour Change WheelJ P L Leenen, E M Dijkman, A van Hout, et al.
Advances in Therapy|January 8, 2022
Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making ApproachMarjanne A Piena, Sonja Kroep, Claire Simons, et al.
Transfusion|June 1, 2006
Costs and benefits of bacterial culturing and pathogen reduction in the NetherlandsMart P Janssen, Cees L van der Poel, Erik Buskens, et al.
Transfusion|September 2, 2011
Cost-effectiveness of additional blood screening tests in the NetherlandsBarbara A Borkent-Raven, Mart P Janssen, Cees L van der Poel, et al.
Haematologica|January 29, 2011
A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia AKathelijn Fischer, Maurice E Pouw, Daniel Lewandowski, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 9, 2002
Association between joint bleeds and Pettersson scores in severe haemophiliaK Fischer, B A van Hout, J G van der Bom, et al.
Pageof 13